Renal Workshop Flashcards
Stages of AKI
Stage 1:
Serum Creatinine - increase by greater than or equal to 26 micromol/L within 48h or 1.5-1.9 times baseline
Urine output: Less than 0.5/ml/kg/hr for 6-12h
Stage 2:
Serum Creatinine - 2-2.9 times baseline
Urine output: Less than 0.5/ml/kg/hr for 12h or more
Stage 3:
Serum Creatinine - 3 times baseline or increase to >354 micromol/L or decrease in eGFR to <35ml/min/1.73 in children and young people or initiation of renal replacement therapy
Urine output: Less than 0.3/ml/kg/hr for 24h or more or no urine for 12h or more
Risk Factors of AKI
- Previous AKI
- Pre-existing CKD
- over 65 years
- congestive cardiac failure
- atherosclerotic peripheral vascular disease
- diabetes
- liver disease
Causes of AKI
Triggers include:
- Sepsis
- Hypovolaemia
- Hypotension
- Certain meds
Causes include:
- Pre renal issues that cause reduced blood flow to kidneys including acute tubular necrosis, sepsis, infections, hypovolaemia and hypotension may all reduce renal blood flow
- Post renal due to obstruction to urine flow from kidneys
- Intrinsic renal causes due to damage to the functional tissues of the kidney
Medicines Management in AKI
- Avoid use of nephrotoxic medication (NSAIDs in CKD patients)
- Monitor renal function (ACE inhibitors, ARBS and diuretics can alter renal function)
- Reviewing medicines that may exacerbate AKI (e.g. temporarily withholding ACE inhibitors, ARBs and NSAIDs if patients become acutely unwell)
Sick Day Rules
- If vomiting (can’t keep fluid down)
- Diarrhoea (can’t replace volume)
- Fever/feverish illness
- STOP
- ACEi/ARBs
- Metformin and it’s combinations
- NSAIDs
- Diuretics
Drug Induced Nephrotoxicity
• Pre-renal – drugs affecting blood flow to the kidneys – Diuretics → hypovoleamia – β blockers → ↓ cardiac output – ACEI → ↓ renal blood flow • Intrinsic – Gentamicin, amphotericin → acute tubular necrosis (ATN) – NSAIDs, penicillins, sulphonamides → TIN – Penicillamine → glomerulonephritis • Post-renal – drugs causing obstruction – Ergotamine, bromocriptine
Care in the community
- Rx’s
- Why sodium bicarb
- Right kind of vitamin D
- Phosphate binders
- Iron folate Vit B12
Chronic Kidney Disease (CKD)
• Long – standing progressive impairment – Rate of progression depends on cause – One suggested pathway – glomerular hyperfiltration • Reversible in some circumstances – Removal of urinary tract obstruction – Correction of arterial narrowing
Symptoms of CKD
• Symptoms of underlying cause • Uraemia – When >40mmol/L • N&V, diarrhoea, malaise, anaemia • ↓ appetite, insomnia, restless legs, paraesthesiae • Oedema, nocturia/polyuria, bone pain – When >50 – 60mmol/L • More severe • Serious CNS symptoms • Oliguria – AKI – End stage renal failure (ESRF)
CKD - complications
• Cardiovascular disease – 16 fold increase in incidence – Large number of risk factors • Anaemia – Due to erythropoietin deficiency • Bone disease (renal osteodystrophy) – Active Vitamin D ↓ and calcium ↓ – Hyperparathyroidism • Skin disease • GI complications • Metabolic abnormalities • Endocrine abnormalities • Uraemic effects
Management of CKD
• Treat underlying cause of CKD • Renoprotection – Control hypertension – ↓ proteinuria • Control of CV risk factors • Correction of anaemia • Management of calcium, phosphate & potassium levels • Suppression of PTH • Transplant
Drug Handling in Renal Impairment
• Absorption – Unpredictable in uraemia • Distribution – ↓ protein binding – affected by fluid overload / depletion • Metabolism – ↓ catabolism – eg insulin – ↓ conversion of precursor to active metabolite • Elimination – ↓ especially in renally excreted drugs • End organ sensitivity – Renal response may be ↓ eg thiazide diuretics